![James Cummings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Cummings
Hoofd Techniek/Wetenschap/O&O bij
VAXART, INC.
Vermogen: 261 714 $ op 30-06-2026
Profiel
Dr. James F.
Cummings, MD, is a Chief Medical Officer at Vaxart, Inc. Dr. Cummings was previously employed as a President & Chief Executive Officer by ICON Government & Public Health Solutions, Inc., a VP-Clinical Development & Translational Medicine by Novavax, Inc., a Director-Defense Department by Global Emerging Infectious Surveillance & Response System, and a Director-Translational Medicine by Walter Reed Army Institute of Research.
He also served on the board at OyaGen, Inc. He received his undergraduate degree from Georgetown University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VAXART, INC. 0,18% | 26-05-2026 | 432.585 ( 0,18% ) | 261 714 $ | 30-06-2026 |
Actieve functies van James Cummings
| Bedrijven | Functie | Begin |
|---|---|---|
| VAXART, INC. | Hoofd Techniek/Wetenschap/O&O | 27-09-2021 |
Eerdere bekende functies van James Cummings
| Bedrijven | Functie | Einde |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Algemeen Directeur | 01-09-2021 |
| NOVAVAX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 01-08-2015 |
Walter Reed Army Institute of Research | Corporate Officer/Principal | 01-03-2009 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Directeur/Bestuurslid | - |
Opleiding van James Cummings
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
34
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Commercial Services |
Walter Reed Army Institute of Research | Electronic Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Global Emerging Infectious Surveillance & Response System |
